Table 2.
Clinicopathological characteristics according to visceral adipose tissue content
| Q1 | Q2 | Q3 | Q4 | P | |
|---|---|---|---|---|---|
| Median age (range) | 57.5 (51.0–62.0) | 60.0 (46.0–68.0) | 46.0 (39.0–57.3) | 51.0 (42.0–54.0) | < 0.001 |
| No. gender, n (%) | |||||
| Male | 24 (48.0%) | 33 (66.0%) | 46 (92.0%) | 50 (100.0%) | < 0.001 |
| Female | 26 (52.0%) | 17 (34.0%) | 4 (8.0%) | 0 (0.0%) | |
| Median tumor size (cm) (range) | 1.8 (1.2–2.8) | 2.5 (1.8–3.6) | 1.6 (1.4–1.7) | 2.1 (1.2–2.9) | < 0.001 |
| Median BMI (kg/m2) (range) | 22.9 (21.9–24.6) | 24.4 (23.0–26.6) | 27.7 (24.1–29.0) | 27.1 (25.1–29.2) | < 0.001 |
| No. comorbid conditions, n (%) | |||||
| Hypertension | 13 (26.0%) | 26 (52.0%) | 9 (18.0%) | 18 (36.0%) | 0.002 |
| Hypercholesterolemia | 0 (0.0%) | 4 (8.0%) | 4 (8.0%) | 8 (16.0%) | 0.034 |
| Diabetes | 8 (16.0%) | 3 (6.0%) | 6 (12.0%) | 3 (6.0%) | 0.261 |
| No. smoking status, n (%) | < 0.001 | ||||
| Never | 35 (70.0%) | 22 (44.0%) | 12 (24.0%) | 6 (12.0%) | |
| Former | 12 (24.0%) | 22 (44.0%) | 22 (44.0%) | 14 (28.0%) | |
| Current | 3 (6.0%) | 6 (12.0%) | 16 (32.0%) | 30 (60.0%) | |
| No. alcohol status, n (%) | |||||
| Never | 28 (56.0%) | 20 (40.0%) | 15 (30.0%) | 6 (12.0%) | < 0.001 |
| Former | 7 (14.0%) | 6 (12.0%) | 9 (18.0%) | 18 (36.0%) | |
| Current | 15 (30.0%) | 24 (48.0%) | 26 (52.0%) | 26 (52.0%) | |
| No. ISUP grade, n (%) | |||||
| Low-grade (1–2) | 10 (20.0%) | 20 (40.0%) | 46 (92.0%) | 40 (80.0%) | < 0.001 |
| High-grade (3–4) | 40 (80.0%) | 30 (60.0%) | 4 (8.0%) | 10 (20.0%) |
Data are presented as medians (interquartile ranges) for continuous variables and as percentage for categorical variables. P values from one-way analysis of variance and chi-square test or Fisher’s exact test were used to determine mean differences for continuous and categorical variables, respectively, based on VAT quartiles. BMI body mass index, SAT subcutaneous adipose tissue, TAT total adipose tissue, VAT visceral adipose tissue, VAT% percentage of visceral adipose tissue